Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial by Farah Rahman, Taryn McLaughlin, Pedro Mesquita, Josee Morin, Diane Potvin, Marilyn De Chantal, Judith A. Aberg

Get full text

Informative Censoring—A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data by Hung-Mo Lin, Sean T. H. Liu, Matthew A. Levin, John Williamson, Nicole M. Bouvier, Judith A. Aberg, David Reich, Natalia Egorova

Get full text

A mobile health intervention in HIV primary care: supporting patients at risk for ART non-adherence by Ana Ventuneac, Emma Kaplan-Lewis, Jessamine Buck, Randi Roy, Caitlin E. Aberg, Bianca A. Duah, Emily Forcht, Michelle Cespedes, Judith A. Aberg

Get full text

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionResearch in context by Jesmond Dalli, Douglas Kitch, Meagan P. O'Brien, Peter W. Hunt, Nicholas Funderburg, Daniela Moisi, Amita Gupta, Todd T. Brown, Phyllis C. Tien, Judith A. Aberg, Rupak Shivakoti

Get full text

Chronic High Risk Prescription Opioid Use Among Persons With HIV by Ana Ventuneac, Gavriella Hecht, Emily Forcht, Bianca A. Duah, Shafaq Tarar, Blanche Langenbach, Jay Gates, Demetria Cain, H. Jonathon Rendina, H. Jonathon Rendina, Judith A. Aberg, David C. Perlman

Get full text

Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities. by Nyasha Bakare, Ivor Ralph Edwards, Andy Stergachis, Shanthi Pal, Charles B Holmes, Marie Lindquist, Chris Duncombe, Alex Dodoo, Joel Novendstern, Jude Nwokike, Ricardo Kuchenbecker, Judith A Aberg, Veronica Miller, Jur Strobos

Get full text

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialResearch in context by Mabel Toribio, Kathleen V. Fitch, Lauren Stone, Markella V. Zanni, Janet Lo, Chris de Filippi, Craig A. Sponseller, Hang Lee, Ida Grundberg, Melanie A. Thompson, Judith A. Aberg, Steven K. Grinspoon

Get full text

Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes. by Joan A Phelan, William R Abrams, Robert G Norman, Yihong Li, Maura Laverty, Patricia M Corby, Jason Nembhard, Dinah Neri, Cheryl A Barber, Judith A Aberg, Gene S Fisch, Michael A Poles, Daniel Malamud

Get full text

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients by Douglas Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav Patel, Tomi Jun, Thomas Jandl, Farah Rahman, Sean T. H. Liu, Judith A. Aberg, Nicole Bouvier, The Mount Sinai Health System Convalescent Plasma Team

Get full text

Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study by Josep M. Llibre, Judith A. Aberg, Sharon Walmsley, Juan Velez, Carlos Zala, Brenda Crabtree Ramírez, Bronagh Shepherd, Rimi Shah, Andrew Clark, Allan R. Tenorio, Amy Pierce, Fangfang Du, Bo Li, Marcia Wang, Shiven Chabria, Michael Warwick-Sanders

Get full text

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 by Judith A. Aberg, Bronagh Shepherd, Marcia Wang, Jose V. Madruga, Fernando Mendo Urbina, Christine Katlama, Shannon Schrader, Joseph J. Eron, Princy N. Kumar, Eduardo Sprinz, Margaret Gartland, Shiven Chabria, Andrew Clark, Amy Pierce, Max Lataillade, Allan R. Tenorio

Get full text

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerab... by Umesh G. Lalloo, Lauren Komarow, Judith A. Aberg, David B. Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A. Larsen

Get full text

Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19 by Catharine I. Paules, Jacqueline A. Nordwall, Kathryn Shaw-Saliba, Judith A. Aberg, Edward M. Gardner, Anna L. Goodman, N. Kumarasamy, Shikha Vasudeva, David M. Vock, Crystal M. North, Jens Lundgren, Neil R. Aggarwal, for the STRIVE Network and TICO Trial Study Group

Get full text

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group. by Caroline H Shiboski, Huichao Chen, Rode Secours, Anthony Lee, Jennifer Webster-Cyriaque, Mahmoud Ghannoum, Scott Evans, Daphné Bernard, David Reznik, Dirk P Dittmer, Lara Hosey, Patrice Sévère, Judith A Aberg, Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group

Get full text

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerab... by Umesh G Lalloo, Lauren Komarow, Judith A Aberg, David B Clifford, Evelyn Hogg, Ashley McKhann, Aggrey Bukuru, David Lagat, Sandy Pillay, Vidya Mave, Khuanchai Supparatpinyo, Wadzanai Samaneka, Deborah Langat, Eduardo Ticona, Sharlaa Badal-Faesen, Robert A Larsen, ACTG A5225 Team

Get full text

Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort. by Allison L Agwu, John A Fleishman, Guy Mahiane, Bareng Aletta Sanny Nonyane, Keri N Althoff, Baligh R Yehia, Stephen A Berry, Richard Rutstein, Ank Nijhawan, Christopher Mathews, Judith A Aberg, Jeanne C Keruly, Richard D Moore, Kelly A Gebo, HIV Research Network

Get full text

Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIVResearch in context by Márton Kolossváry, Chris deFilippi, Sara McCallum, Kathleen V. Fitch, Marissa R. Diggs, Evelynne S. Fulda, Heather J. Ribaudo, Carl J. Fichtenbaum, Judith A. Aberg, Carlos D. Malvestutto, Judith S. Currier, Jose L. Casado, Félix Gutiérrez, Irini Sereti, Pamela S. Douglas, Markella V. Zanni, Steven K. Grinspoon

Get full text

Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial by Gabriela Cedillo, Mary Catherine George, Richa Deshpande, Emma K. T. Benn, Allison Navis, Alexandra Nmashie, Alina Siddiqui, Bridget R. Mueller, Yosuke Chikamoto, Linda Weiss, Maya Scherer, Alexandra Kamler, Judith A. Aberg, Barbara G. Vickrey, Angela Bryan, Brady Horn, Angela Starkweather, Jeffrey Fisher, Jessica Robinson-Papp

Get full text

Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV by Samuel R. Schnittman, Wonyeong Jung, Kathleen V. Fitch, Markella V. Zanni, Sara McCallum, Jessica Shih-Lu Lee, Sally Shin, Brandon J. Davis, Evelynne S. Fulda, Marissa R. Diggs, Francoise Giguel, Romina Chinchay, Anandi N. Sheth, Carl J. Fichtenbaum, Carlos Malvestutto, Judith A. Aberg, Judith Currier, Douglas A. Lauffenburger, Pamela S. Douglas, Heather J. Ribaudo, Galit Alter, Steven K. Grinspoon

Get full text

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative by Hector Bonilla, Michael J. Peluso, Kathleen Rodgers, Judith A. Aberg, Thomas F. Patterson, Robert Tamburro, Lawrence Baizer, Jason D. Goldman, Jason D. Goldman, Nadine Rouphael, Amelia Deitchman, Jeffrey Fine, Paul Fontelo, Arthur Y. Kim, Gwendolyn Shaw, Jeran Stratford, Patricia Ceger, Maged M. Costantine, Liza Fisher, Lisa O’Brien, Christine Maughan, John G. Quigley, Vilma Gabbay, Sindhu Mohandas, David Williams, Grace A. McComsey

Get full text